학술논문

FGF23, Frailty, and Falls in SPRINT

Document Type

article

Author

Jovanovich, Anna; Ginsberg, Charles; You, Zhiying; Katz, Ronit; Ambrosius, Walter T; Berlowitz, Dan; Cheung, Alfred K; Cho, Monique; Lee, Alexandra K; Punzi, Henry; Rehman, Shakaib; Roumie, Christianne; Supiano, Mark A; Wright, Clinton B; Shlipak, Michael; Ix, Joachim H; Chonchol, Michel

Source

Journal of the American Geriatrics Society. 69(2)

Subject

Aging
Clinical Trials and Supportive Activities
Kidney Disease
Hypertension
Clinical Research
Prevention
Accidental Falls
Aged
Biomarkers
Correlation of Data
Cross-Sectional Studies
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Frailty
Glomerular Filtration Rate
Humans
Male
Renal Insufficiency
Chronic
fibroblast growth factor 23
falls
frailty
chronic kidney disease
biomarkers
Medical and Health Sciences
Geriatrics

Language

Abstract

Background/objectivesChronic kidney disease (CKD) is associated with frailty. Fibroblast growth factor 23 (FGF23) is elevated in CKD and associated with frailty among non-CKD older adults and individuals with human immunodeficiency virus. Whether FGF23 is associated with frailty and falls in CKD is unknown.DesignCross-sectional and longitudinal observational study.SettingSystolic Blood Pressure Intervention Trial (SPRINT), a randomized trial evaluating standard (systolic blood pressure [SBP]

Online Access

Open Access (eScholarship) Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송